Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
An Open-label, Phase 2trial of Sotorasib in KRAS G12C-mutant Non-small-cell Lung Cancer(NSCLC) Patients and a Translational Study to Find Acquired Resistance Mechanism to Sotorasib
ClinicalTrials.gov study NCT05451056. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT01647789. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Prediction of Platinum Resistance and Prognosis of High-grade Serous Ovarian Cancer
ClinicalTrials.gov study NCT06787170. IPD Sharing: NO. Countries: 1. Publications: 0.
Tyrosine Kinase Inhibitors (TKIs) in Trastuzumab Emtansine (T-DM1) Resistant HER2-positive Metastatic Breast Cancer: A Real-world Study
ClinicalTrials.gov study NCT05231863. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT01591122. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT04272645. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT05636111. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluate Safety, Whole-Body Distribution and Radiation Dosimetry in Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT06359821. IPD Sharing: NO. Countries: 1. Publications: 0.
Trametinib in Treating Patients With Progressive Metastatic Hormone-Resistant Prostate Cancer
ClinicalTrials.gov study NCT02881242. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
ClinicalTrials.gov study NCT05465941. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT02049190. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sequential Study of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT07363486. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)
ClinicalTrials.gov study NCT07286266. IPD Sharing: YES. Countries: 0. Publications: 0.
Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT04109729. IPD Sharing: NO. Countries: 1. Publications: 0.
Dissecting the Pathways of Therapy Resistance in Early Breast Cancer
ClinicalTrials.gov study NCT04995575. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)
ClinicalTrials.gov study NCT06104449. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Re-treatment With [177Lu]Lu-PSMA in Men With Metastatic Castration Resistance Prostate Cancer
ClinicalTrials.gov study NCT06866938. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Castration Resistant Prostate Cancer (TheraPb - Phase I/II Study).
ClinicalTrials.gov study NCT05720130. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)
ClinicalTrials.gov study NCT06691984. IPD Sharing: YES. Countries: 22. Publications: 0.
Anlotinib for Patients With Platinum Resistant or Refractory Ovarian Cancer
ClinicalTrials.gov study NCT03924882. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.